Glaucoma MIGS and Meds: Keeping an Eye on New Advances
This activity is supported by an educational grant from AbbVie Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from AbbVie Inc.
Activity Description
The burden of irreversible vision loss from glaucoma continues to rise. Early intervention is key, but despite the effectiveness of available anti-glaucoma therapies, compliance continues to be problematic. Many of the topical glaucoma therapies, particularly those that include preservatives, can cause damage to the ocular surface, resulting in a lack of tolerability that may limit adherence. While they can be an effective initial therapy in many patients, studies have shown that it is often necessary to use multiple topical medications to achieve a target intraocular pressure (IOP). Improved drug-delivery systems may be one solution to this problem, and several sustained-release delivery systems are under investigation to mitigate the burden of daily medication.
Regarding surgical approaches for glaucoma, treatment modalities such as minimally invasive glaucoma surgery (MIGS) offer rapid and effective reduction of IOP, maintain a good safety profile, and use ab interno procedures with minimal tissue trauma and faster recovery. The vast number of recently developed MIGS techniques not only has provided clinicians with a wide range of therapeutic options, but also they have enabled physicians to refine their therapies, contributing to a more patient-centered decision-making process.
This educational activity will explore the sustained-release medications that can improve overall outcomes and compliance to therapy as well as the available MIGS procedures for patients with glaucoma. Expert faculty will review the supporting clinical data for each therapeutic approach and provide practical tips when employing these therapies, including individualizing therapy for specific patients.
Target Audience
The intended audience for this activity is ophthalmologists and other healthcare professionals involved in the management of patients with glaucoma.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Describe novel, minimally invasive glaucoma surgical procedures that can improve overall outcomes in patients.
- Recognize how the use of sustained-release glaucoma medications can improve adherence and compliance to therapy.
Activity Chair
Analisa Arosemena, MD
Glaucoma and Anterior Segment Surgeon
Aran Eye Associates
Miami, FL
Faculty
Sahar Bedrood, MD, PhD
Glaucoma and Cataract Surgeon
Advanced Vision Care
Adjunct Clinical Assistant Professor
USC Roski Eye Institute
Los Angeles, CA
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, October 31, 2023, to October 30, 2024.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Analisa Arosemena, MD
Advisor: Allergan, New World Medical, Nova Eye
Consultant: Sight Sciences
Speaker Contracted by Ineligible Company: Alcon, Allergan, New World Medical, Nova Eye, Sight Sciences
Individual Stocks and Stock Options: AbbVie
Sahar Bedrood, MD, PhD
Consultant: Allergan, Belkin, BVI, Glaukos, MST Pharma, Ocular Therapeutix, Thea
Speaker Contracted by Ineligible Company: Allergan, Glaukos
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this lecture is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com